岭南现代临床外科
嶺南現代臨床外科
령남현대림상외과
LINGNAN MODERN CLINICS IN SURGERY
2014年
3期
251-255
,共5页
谭明华%朱劲涛%吕益中%彭亮
譚明華%硃勁濤%呂益中%彭亮
담명화%주경도%려익중%팽량
低位直肠癌%腹腔镜%Dixon术%Miles术
低位直腸癌%腹腔鏡%Dixon術%Miles術
저위직장암%복강경%Dixon술%Miles술
Low rectal cancer%Laparoscopic%Dixon surgery%Miles surgery
目的:探讨比较腹腔镜辅助Dixon根治术与腹腔镜辅助Miles根治术治疗低位直肠癌的可行性、安全性及疗效。方法回顾性分析我院在我院符合入组及排除标准的低位直肠癌腹腔镜手术患者,按照术式分为Dixon组(41例)和Miles组(42例)。分析两组患者的临床病理资料、手术质量、术后康复情况及预后、复发资料。结果 Dixon组与Miles组的临床病理资料并无显著的统计学分布差异。尽管Dixon组的手术时间及术中出血量优于Miles组,但Miles组的术后费用显著少于Dixon组的患者。两组患者的术后获取淋巴结总数及获取阳性淋巴结个数无明显的差别,肠道功能恢复时间亦相近,差异无统计学意义。 Dixon组术后总体并发症发生率为17.0%,吻合口瘘的发生率为7.3%,Miles组患者术后总体并发症的发生率为21.4%,与Dixon相比差异未具有显著的统计学意义(P>0.05)。Dixon组患者术后5年预期总体生存率为60.6%,与Miles组的56.2%相近,差异未见统计学意义(P>0.05)。在随访期间,Dixon与Miles组患者复发率无明显差异,分别为12.2%及11.9%。结论腹腔镜低位直肠癌Dixon根治术肿瘤根治程度与腹腔镜辅助Miles根治术无明显差别,安全可靠,长期生存预后不逊于Miles手术。
目的:探討比較腹腔鏡輔助Dixon根治術與腹腔鏡輔助Miles根治術治療低位直腸癌的可行性、安全性及療效。方法迴顧性分析我院在我院符閤入組及排除標準的低位直腸癌腹腔鏡手術患者,按照術式分為Dixon組(41例)和Miles組(42例)。分析兩組患者的臨床病理資料、手術質量、術後康複情況及預後、複髮資料。結果 Dixon組與Miles組的臨床病理資料併無顯著的統計學分佈差異。儘管Dixon組的手術時間及術中齣血量優于Miles組,但Miles組的術後費用顯著少于Dixon組的患者。兩組患者的術後穫取淋巴結總數及穫取暘性淋巴結箇數無明顯的差彆,腸道功能恢複時間亦相近,差異無統計學意義。 Dixon組術後總體併髮癥髮生率為17.0%,吻閤口瘺的髮生率為7.3%,Miles組患者術後總體併髮癥的髮生率為21.4%,與Dixon相比差異未具有顯著的統計學意義(P>0.05)。Dixon組患者術後5年預期總體生存率為60.6%,與Miles組的56.2%相近,差異未見統計學意義(P>0.05)。在隨訪期間,Dixon與Miles組患者複髮率無明顯差異,分彆為12.2%及11.9%。結論腹腔鏡低位直腸癌Dixon根治術腫瘤根治程度與腹腔鏡輔助Miles根治術無明顯差彆,安全可靠,長期生存預後不遜于Miles手術。
목적:탐토비교복강경보조Dixon근치술여복강경보조Miles근치술치료저위직장암적가행성、안전성급료효。방법회고성분석아원재아원부합입조급배제표준적저위직장암복강경수술환자,안조술식분위Dixon조(41례)화Miles조(42례)。분석량조환자적림상병리자료、수술질량、술후강복정황급예후、복발자료。결과 Dixon조여Miles조적림상병리자료병무현저적통계학분포차이。진관Dixon조적수술시간급술중출혈량우우Miles조,단Miles조적술후비용현저소우Dixon조적환자。량조환자적술후획취림파결총수급획취양성림파결개수무명현적차별,장도공능회복시간역상근,차이무통계학의의。 Dixon조술후총체병발증발생솔위17.0%,문합구루적발생솔위7.3%,Miles조환자술후총체병발증적발생솔위21.4%,여Dixon상비차이미구유현저적통계학의의(P>0.05)。Dixon조환자술후5년예기총체생존솔위60.6%,여Miles조적56.2%상근,차이미견통계학의의(P>0.05)。재수방기간,Dixon여Miles조환자복발솔무명현차이,분별위12.2%급11.9%。결론복강경저위직장암Dixon근치술종류근치정도여복강경보조Miles근치술무명현차별,안전가고,장기생존예후불손우Miles수술。
Objective To compare the the therapeutical effect between laparoscopic assisted Dixon and Miles radical resection for low rectal cancer. Methods Eighty-three patients with low rectal cancer who received laparoscopic assisted surgery were included in the study according to the inclusion and exclusion criteria from January 2008 to December 2010. .The enrolled patients were divided into two groups: Dixon group (41 cases) and Miles group (42 cases). The clinicopathological data, surgical quality, postoperative survival and recurrence data were compared between two groups. Results There were no distribution differences in clinical data between Dixon group and Miles group. The mean operative time and intraoperative blood loss in Dixon group were shorter than that in Miles group (P<0.05), however the Miles group cost less postoperatively. No differences were found between two groups in the numbers of lymph nodes harvested postoperatively and positive lymph nodes. Both two groups had similar bowel function recover time..The overall postoperative complication rate in Dixon group was 17.0% and 21.4% in the Miles group (P>0.05)..The postoperative 5-years overall survival rate of Dixon and Miles group was 60.6% and 56.2% respectively and no survival difference was found between them..During follow-up period,.the recurrence rates between Dixon and Miles groups were similar (12.2% vs 11.9%,.P>0.05)...Conclusions Laparoscopic assisted Dixon radical opera-tion for low rectal cancer was a safe surgical procedure and had similar clinical effect with laparoscopic assisted Miles rectal surgery..The long-term survival outcome of laparoscopic assisted Dixon surgery was similar to laparoscopic assisted Miles surgery.